Details.
A study investigating new methods of diagnosing and monitoring metabolic dysfunction-associated steatotic liver disease. For patients aged 23 to 75 with a BMI from 25 kg/m2. Involves 2 screening visits and 2 one-day sessions.
at London Trials · London
A study investigating new methods of diagnosing and monitoring metabolic dysfunction-associated steatotic liver disease. For patients aged 23 to 75 with a BMI from 25 kg/m2. Involves 2 screening visits and 2 one-day sessions.
Get the app to book and see what else is on nearby.